Development and validation of an interpretable machine learning model for predicting progression-free survival after immunotherapy in patients with non-small cell lung cancer: a multicenter study
BackgroundThis study aimed to develop and validate an interpretable machine learning model that harnesses circulating tumor DNA (ctDNA) to predict progression-free survival (PFS) in patients with non-small cell lung cancer (NSCLC) undergoing immunother…